Adenosquamous Carcinoma of the Endometrium - 13 Studies Found
Completed |
: Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer :
|
Completed |
: Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer :
|
Active, not recruiting |
: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer :
|
Active, not recruiting |
: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer :
|
Completed |
: Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer :
|
Recruiting |
: Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer :
|
Completed |
: Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer :
|
Recruiting |
: Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer :
|
Active, not recruiting |
: Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer :
|
Active, not recruiting |
: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer :
|